Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland Tumors.
Journal
The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005
Informations de publication
Date de publication:
01 Feb 2021
01 Feb 2021
Historique:
pubmed:
23
6
2020
medline:
13
10
2021
entrez:
23
6
2020
Statut:
ppublish
Résumé
Extraocular sebaceous carcinoma (ESC) is a rare appendiceal skin tumor. In contrast to ocular sebaceous carcinoma, information about the exact cellular architecture of these lesions is scarce and the histogenesis of ESC is unknown. Here, we extend our previous study and investigate 28 extraocular carcinomas in comparison to 54 benign sebaceous tumors and 8 cases of normal sebaceous glands using a broad spectrum of antibodies against p63, several keratins, adipophilin, EMA, Ki67, androgen receptor, and mismatch repair proteins. This observational study demonstrates that p63- and K5/14-positive basaloid cells are key cells in normal sebaceous gland and in all sebaceous tumors and that these basaloid cells give rise to EMA+, adipophilin+ sebocytes, and K5/14+, K7±, K10± ductal structures. Finally, about half of ESC is associated with superficial in situ neoplasia, which provides evidence that at least part of these carcinomas arises from flat superficial in situ carcinoma. In contrast to the normal sebaceous gland, about half of all sebaceous tumors lack keratin K7. MMR protein IHC-profiles role will be discussed.
Identifiants
pubmed: 32568835
pii: 00000372-202102000-00002
doi: 10.1097/DAD.0000000000001667
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
93-102Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Park SK, Park J, Kim HU, et al. Sebaceous carcinoma: clinicopathologic analysis of 29 cases in a tertiary hospital in korea. J Korean Med Sci. 2017;32:1351–1359.
Wick MR, et al. WHO Classification of Skin Tumours, Vol. 11th. 4th ed. Elder DE, Maszi D, Scolyer RA, et al, eds. Lyon: IARC; 2018:211–215.
Bolm I, Babaryka G, Moergel M, et al. Multifocal metastasizing extra-ocular facial sebaceous carcinoma as diagnostic challenge: case report and systematic review. J Maxillofac Oral Surg. 2015;14:331–337.
Brown M. Commentary on sebaceous carcinoma. Dermatol Surg. 2015;41:16–17.
Chang AY, Miller CJ, Elenitsas R, et al. Management considerations in extraocular sebaceous carcinoma. Dermatol Surg. 2016;42(suppl 1):S57–S65.
Choi YJ, Jin HC, Lee MJ, et al. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea. Jpn J Ophthalmol. 2014;58:327–333.
Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115:158–165.
Hadravsky L, Kazakov DV, Stehlik J, et al. Aggressive extraocular sebaceous carcinoma of the scalp involving the brain in a patient with muir-torre syndrome. Am J Dermatopathol. 2016;38:618–622.
Kumar V, Xu Y. Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer for guiding chemotherapy in rare tumours? Curr Oncol. 2015;22:e316–e319.
Kyllo RL, Brady KL, Hurst EA. Sebaceous carcinoma: review of the literature. Dermatol Surg. 2015;41:1–15.
Orcurto A, Gay BE, Sozzi WJ, et al. Long-term remission of an aggressive sebaceous carcinoma following chemotherapy. Case Rep Dermatol. 2014;6:80–84.
Osada S, Ueno T, Inai S, et al. Sebaceous carcinoma of the nose with a regional metastasis following false-negative sentinel lymph node biopsy. Acta Derm Venereol. 2011;91:367–368.
Ansai S, Arase S, Kawana S, et al. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies. J Dermatol. 2011;38:951–958.
Ansai S, Takeichi H, Arase S, et al. Sebaceous carcinoma: an immunohistochemical reappraisal. Am J Dermatopathol. 2011;33:579–587.
Asadi-Amoli F, Khoshnevis F, Haeri H, et al. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma. Am J Clin Pathol. 2010;134:22–26.
Boussahmain C, Mochel MC, Hoang MP. Perilipin and adipophilin expression in sebaceous carcinoma and mimics. Hum Pathol. 2013;44:1811–1816.
Plaza JA, Mackinnon A, Carrillo L, et al. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study. Am J Dermatopathol. 2015;37:809–821.
Jakobiec FA, Werdich X. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas. Am J Ophthalmol. 2014;157:687–696.e1-2.
Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol. 1999;21:426–431.
Frances D, Niemann C. Stem cell dynamics in sebaceous gland morphogenesis in mouse skin. Dev Biol. 2012;363:138–146.
Blanpain C, Fuchs E. Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration. Science. 2014;344:1242281.
Taylor G, Lehrer MS, Jensen PJ, et al. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell. 2000;102:451–461.
Horsley V, O'Carroll D, Tooze R, et al. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell. 2006;126;597–609.
Oshima H, Rochat A, Kedzia C, et al. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell. 2001;104:233–245.
Shalin SC, Lyle S, Calonje E, et al. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications. Histopathology. 2010;56:133–147.
North JP, Golovato J, Vaske CJ, et al. Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. Nat Commun. 2018;9:1894.
Boecker W, Reusch M, Mielke V, et al. Spatial analysis of p63, K5 and K7 defines two groups of progenitor cells that differentially contribute to the maintenance of normal sebaceous glands, extraocular sebaceous carcinoma and benign sebaceous tumors. J Dermatol. 2019;46:249–258.
Buchwalow I, Boecker W, Wolf E, et al. Signal amplification in immunohistochemistry: loose-jointed deformable heteropolymeric HRP conjugates vs. linear polymer backbone HRP conjugates. Acta Histochem. 2013;115:587–594.
Buchwalow IB, Boecker W. Immunohistochemistry: Basics and Methods. 1st ed. Heidelberg, Dordrecht, London, New York: Springer; 2010.
Buchwalow IB, Minin EA, Boecker W. A multicolor fluorescence immunostaining technique for simultaneous antigen targeting. Acta Histochem. 2005;107:143–148.
Buchwalow I, Samoilova V, Boecker W, et al. Multiple immunolabeling with antibodies from the same host species in combination with tyramide signal amplification. Acta Histochem. 2018;120:405–411.
Jessup CJ, Redston M, Tilton E, et al. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome. Hum Pathol. 2016;49:1–9.
Requena L, Sangüeza O. Cutaneous Adnexal Neoplasms. Vol 58. Requena L, Sangüeza O, eds. Berlin, Germany: Springer; 2018:755–943.
Ivan D, Prieto VG, Aung PP. Use of Immunohistochemical and Molecular Stuidies in the Evaluation of the Sebaceous Neoplasms. Berlin, Germany: Springer Nature; 2016:81–99.
Prieto VG. Immunohistology of Skin Tumors. 4th Edition Edn, Vol. Diagnnostic Immunohistochemistry: Theranostic and Genomic Applications. München, Germany: Elsevier Saunders; 2014:479–507.
Kazakov M, Michal M, Kacerovska D, et al. Cutaneous Adnexal Tumors. Deutschland: Wolters Kluwer; 2012.
Flux K, Kutzner H, Rütten A, et al. Infundibulocystic structures and prominent squamous metaplasia in sebaceoma-A rare feature. A clinicopathologic study of 10 cases. Am J Dermatopathol. 2016;38:678–682.
Komforti MK, Asgari M, Chen S. Sebaceous carcinoma in situ as a concept and diagnostic entity. Dermatol Pract Concept. 2017;7:27–31.
Kazakov DV, Kutzner H, Spagnolo DV, et al. What is extraocular cutaneous sebaceous carcinoma in situ? Am J dermatopathology. 2010;32;857–858.
Currie GP, Plaza JA, Harris GJ. Intraepithelial sebaceous carcinoma: a case report of an unusual occurrence. Am J Dermatopathol. 2014;36:673–676.
Misago N, Toda S, Narisawa Y. Two histopathologic patterns of well-differentiated extraocular sebaceous carcinoma. J Cutan Pathol. 2011;38:767–774.
Nakashima K, Adachi K, Yamasaki A, et al. Sebaceous carcinoma with actinic keratosis. Acta Derm Venereol. 2010;90:196–198.
Misago N, Kuwashiro M, Tsuruta N, et al. Sebaceous carcinoma in association with actinic keratosis: a report of two cases with an immunohistochemical study. J Dermatol. 2015;42:616–620.
Omori Y, Tanito K, Ito K, et al. Bowen's carcinoma of the penis with sebaceous differentiation associated with human papillomavirus type 16. Int J Dermatol. 2014;53:e531–e532.
Ishida M, Iwai M, Yoshida K, et al. Sebaceous carcinoma associated with Bowen's disease: a case report with emphasis on the pathogenesis of sebaceous carcinoma. Int J Clin Exp Pathol. 2013;6:3029–3032.
Ishida M, Okabe H. Intraepidermal sebaceous carcinoma occurring concurrently with actinic keratosis. J Cutan Pathol. 2012;39:731–732.
Cesinaro AM, Ubiali A, Sighinolfi P, et al. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer. Am J Dermatopathol. 2007;29:351–358.
Fernandez-Flores A. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome. Am J Dermatopathol. 2012;34:416–422.
Kuwabara K, Suzuki O, Chika N, et al. Prevalence and molecular characteristics of DNA mismatch repair protein-deficient sebaceous neoplasms and keratoacanthomas in a Japanese hospital-based population. Jpn J Clin Oncol. 2018;48:514–521.
Lamba AR, Moore AY, Moore T, et al. Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome. Fam Cancer. 2015;14:259–264.
Mathiak M, Rütten A, Mangold E, et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol. 2002;26:338–343.
Ponti G, Longo C. Microsatellite instability and mismatch repair protein expression in sebaceous tumors, keratocanthoma, and basal cell carcinomas with sebaceous differentiation in Muir-Torre syndrome. J Am Acad Dermatol. 2013;68:509–510.
Rajan KdA, Burris C, Iliff N, et al. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. Am J Ophthalmol. 2014;157:640–647 e641-642.
Singh RS, Grayson W, Redston M, et al. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol. 2008;32:936–942.
Jakobiec FA, Mendoza PR. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. Am J Ophthalmol. 2014;157:186–208 e182.
Izumi M, Tang X, Chiu CS, et al. Ten cases of sebaceous carcinoma arising in nevus sebaceus. J Dermatol. 2008;35:704–711.
Mulay K, White VA, Shah SJ, et al. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Can J Ophthalmol. 2014;49:326–332.
Mulay K, Shah SJ, Aggarwal E, et al. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance? Acta Ophthalmol. 2014;92:e681–e687.
Robson A, Lazar AJ, Ben Nagi J, et al. Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol. 2008;32:682–690.